Ashley Farione, PA-C | Authors

Articles

Case 3: Newly Diagnosed High-Grade Serous Carcinoma

February 11, 2022

Experts in gynecologic oncology review the case of a 69-year-old woman with newly diagnosed high-serous carcinoma and discuss their approach to maintenance therapy after first-line chemotherapy plus bevacizumab.

Case 2: Monitoring Adverse Reactions With Niraparib Maintenance in Ovarian Cancer

February 04, 2022

Cecelia H. Boardman, MD, John K. Chan, MD, and Thomas C. Krivak, MD, share strategies for monitoring adverse events and the optimal duration for niraparib maintenance therapy for a patient with advanced ovarian cancer.

Case 2: Maintenance Strategies for Advanced Ovarian Cancer

February 04, 2022

Thomas C. Krivak, MD; John K. Chan, MD; Cecelia H. Boardman, MD; and Ashley Farione, PA-C, review the optimal approach to maintenance therapeutic options for a patient with stage III, high-grade serous epithelial ovarian cancer.

Case 2: Stage III, High-Grade Serous Epithelial Ovarian Cancer

February 04, 2022

Experts in gynecologic oncology review the case of a 71-year-old woman who is diagnosed with stage III, high-grade serous epithelial ovarian cancer, and comment on their approach to genetic testing in the frontline setting.